Boston, MA -- (SBWIRE) -- 09/10/2013 -- Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner. Chartpoppers.com issues news alert on the following stocks:- Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), ARCAM AB ORD (OTCMKTS:AMAVF), OncoSec Medical Inc (OTCMKTS:ONCS), FUSE SCIENCE, INC (OTCMKTS:DROP)
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) completed latest trade 1.20% higher at $63.39 from prior close of $62.64. It was exchanged between $62.50 – 63.50 with 200,594.00 in overall exchanged numbers of shares. Summarizing after the recent close, its 52 week low price was $45.89 while its 52 week highest price stood at $66.52. Roche Holding AG operates in the pharmaceuticals and diagnostics businesses in Switzerland, European Union, and internationally. It discovers, develops, and delivers diagnostic and therapeutic products and services that enable patients and healthcare professionals in the detection, prevention, diagnosis, treatment, and treatment monitoring of diseases.
For How Long RHHBY will Fight for Profitability? Read This Trend Analysis report
ARCAM AB ORD (OTCMKTS:AMAVF) during the previous trading period, showed a negative activity of -7.42%. Currently, the company has a market capital of $404.46 million dollars. The stock’s final trade was made at $90.03, while it had started its day-trade at $95.96. In the past 52-week period, the stock has not gone below $10.28 and traded at maximum level of $116.49. Arcam AB provides additive manufacturing solutions for the production of metal components. The company offers Arcam Q10, an electron beam melting (EBM) machine for the industrial production of orthopedic implants.
Has AMAVF Found The Bottom And Ready To Gain Momentum? Find Out Here
OncoSec Medical Inc (OTCMKTS:ONCS) increased 3.15% to close at $0.350 in the last trading session and its total traded volume was 3.31 million shares versus average volume of 1.44 million. The company has market cap of $30.94 million.
The stock has positive year-to-date performance of 64.32% while its quarterly performance remained 31.09%.OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology.
Will ONCS Continue To Move Higher? Find Out Here
FUSE SCIENCE, INC (OTCMKTS:DROP) advanced -2.21% and closed at $0.0665 in the last trading session with the overall traded volume of 5.23 million shares, more versus the average volume of 1.11 million shares. Its 52 weeks high price was $0.28 and suffered lowest price of $0.06 in the same period.
It has market cap of $18.62 million. The stock’s 3 month performance stands at -33.5%.Fuse Science, Inc., a consumer products company, develops alternative delivery systems with applications in the sports nutrition and medical fields.
Will DROP Get Buyers Even After The Recent Rally? Find Out Here
Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit chartpoppers right now and see what it’s all about for yourself! At 50,000 Visitors a Month and growing rapidly chartpoppers is the hottest thing in Penny Stocks!
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ChartPoppers.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ChartPoppers.com is owned and operated by One22 Media,LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ChartPoppers’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ChartPoppers or an offer or solicitation to buy or sell any security. Neither the owner of ChartPoppers nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters.
Read Full Disclaimer at: http://chartpoppers.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)